Acadia Pharmaceuticals (ACAD) Profit After Tax (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Acadia Pharmaceuticals | 3.69 Bn | 2.84 Bn | 243.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -98.67% |
| Dec 31, 2025 | 281.13% |
| Sep 30, 2025 | 169.18% |
| Jun 30, 2025 | 40.44% |
| Mar 31, 2025 | -86.79% |
| Dec 31, 2024 | 338.71% |
| Sep 30, 2024 | -1.87% |
| Jun 30, 2024 | 101.69% |
| Mar 31, 2024 | -63.85% |
| Dec 31, 2023 | 170.27% |
| Sep 30, 2023 | -5,950.63% |
| Jun 30, 2023 | 102.59% |
| Mar 31, 2023 | -3.11% |
| Dec 31, 2022 | -53.50% |
| Sep 30, 2022 | 20.08% |
| Jun 30, 2022 | 69.92% |
| Mar 31, 2022 | -162.35% |
| Dec 31, 2021 | -198.08% |
| Sep 30, 2021 | 67.05% |
| Jun 30, 2021 | 33.98% |
| Mar 31, 2021 | 0.47% |
| Dec 31, 2020 | 21.14% |
| Sep 30, 2020 | -100.90% |
| Jun 30, 2020 | 52.13% |
| Mar 31, 2020 | -65.97% |
| Dec 31, 2019 | -26.34% |
| Sep 30, 2019 | 23.59% |
| Jun 30, 2019 | 35.59% |
| Mar 31, 2019 | -30.25% |
| Dec 31, 2018 | -5.40% |
| Sep 30, 2018 | 1.78% |
| Jun 30, 2018 | -16.52% |
| Mar 31, 2018 | 21.16% |
| Dec 31, 2017 | -5.55% |
| Sep 30, 2017 | 3.25% |
| Jun 30, 2017 | 23.23% |
| Mar 31, 2017 | -11.62% |
| Dec 31, 2016 | -9.89% |
| Sep 30, 2016 | -0.41% |
| Jun 30, 2016 | -43.33% |
| Mar 31, 2016 | -8.69% |
| Dec 31, 2015 | -17.68% |
| Sep 30, 2015 | 1.20% |
| Jun 30, 2015 | 2.47% |
| Mar 31, 2015 | -42.34% |
| Dec 31, 2014 | -14.44% |
| Sep 30, 2014 | -15.31% |
| Jun 30, 2014 | -20.57% |
| Mar 31, 2014 | -47.96% |
| Dec 31, 2013 | -12.66% |
| Sep 30, 2013 | -17.77% |
| Jun 30, 2013 | -48.31% |
| Mar 31, 2013 | 10.09% |
| Dec 31, 2012 | -183.51% |
| Sep 30, 2012 | 55.67% |
| Jun 30, 2012 | 12.85% |
| Mar 31, 2012 | -17.32% |
| Dec 31, 2011 | -4.41% |
| Sep 30, 2011 | 22.57% |
| Jun 30, 2011 | -12.39% |
| Mar 31, 2011 | -120.02% |
| Dec 31, 2010 | 789.40% |